Track Medtech Start-ups

Learn More
innovation hub

RhinoCyte is Profiled in this Database

Updated At 11 Mar, 2009

Start Free 7 Day Trial Now
Partial description of this company
Autologous adult stem cell technology, cultured from the nasal passageway, to repair damage resulting from spinal cord injury

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of RhinoCyte plus 4750 other startups.

Start Free 7 Day Trial Now

Learn More About RhinoCyte

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

More

Our Clients